Prostaglandin E1 increases cGMP levels in beating rabbit atria: Lack of effects of PGE1-induced cyclic nucleotides on secretory and contractile functions

Korean Journal of Physiology and Pharmacology

Volumn 11, Issue 5, 2007, Pages 175-182

  Jin, Xuan Shun ^a   Quan, He Xiu ^a   Kim, Sun Young ^a   Park, Sung Hun ^a   Kim, Sung Zoo ^a   Lee, Ho Sub ^b   Cho, Kyung Woo ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Wonkwang University   (South Korea)

Author keywords

Atrial function; Atrial natriuretic peptide; cAMP; cGMP; Prostagladin E1

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ATRIAL NATRIURETIC FACTOR; CYCLIC AMP; CYCLIC GMP; CYCLIC NUCLEOTIDE; GUANYLATE CYCLASE INHIBITOR; ISOPRENALINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN E; PROSTAGLANDIN E1; PROSTAGLANDIN E2;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HEART ATRIUM CONTRACTILITY; HEART ATRIUM CONTRACTION; HEART ATRIUM FUNCTION; HEART MUSCLE CELL; MUSCLE FIBER CONTRACTION; NONHUMAN; RABBIT; SIGNAL TRANSDUCTION;

EID: 36549029301     PISSN: 12264512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Alexander RW, Kent KM, Pisano JJ. Regulation of postocclusive hyperemia by endogenously synthesized prostaglandin in the dog heart. J Clin Invest 55: 1174-1181, 1975
2. Azizi C, Barthelemy C, Masson F, Maistre G, Eurin J, Carayon A. Myocardial production of prostaglandins: its role in atrial natriuretic peptide release. Eur J Endocrinol 133: 255-259, 1995
3. Bellamy TC, Wood J, Goodwin DA, Garthwaite J. Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses. Proc Natl Acad Sci USA 97: 2928-2933, 2000
4. Booz GW. Putting the brakes on cardiac hypertrophy. Exploiting the NO-cGMP counter-regulatory system. Hypertension 45: 341-346, 2005
5. Breyer RM, Emeson RB, Tarng JL, Breyer MD, Davis LS, Abnomson RM, Ferrenbach SM. Alternative splicing generates multiple isoforms of a rabbit prostaglandin E2 receptor. J Biol Chem 269: 6163-6169, 1994
6. Brunton LL, Hayes JS, Mayer SE. Hormonally specific phosphorylation of cardiac troponin I and activation of glycogen phosphorylase. Nature 280: 78-80, 1979
7. Castleberry TA, Lu B, Smock SL, Owen TA. Molecular cloning and functional characterization of the canine prostaglandin E2 receptor EP4 subtype. Prostaglandins Other Lipid Mediat 65: 167-187, 2001
8. Cho KW, Kim SH, Kim CH, Seul KH. Mechanical basis of atrial natriuretic peptide secretion in beating atria: atrial stroke volume and ECF translocation. Am J Physiol 268: R1129-R1136, 1995
9. Cui X, Wen JF, Jin H, Li D, Jin JY, Kim SH, Kim SZ, Lee HS, Cho KW. Subtype-specific roles of cAMP phosphodiesterases in regulation of atrial natriuretic peptide release. Eur J Pharmacol 451: 295-302, 2002a.
10. 2+-independent cAMP inhibition of ANP release in beating rabbit atria. Am J Physiol 282: R1477-R1489, 2002b
11. Das A, Xi L, Kukreja RC. Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling. J Biol Chem 280: 12944-12955, 2005
12. Fiedler VB. Role of arachidonic acid metabolites in cardiac ischemia and reperfusion injury. Pharmacotherapy 8: 158-168, 1988
13. Gardner DG, Schultz HD. Prostaglandins regulate the synthesis and secretion of the atrial natriuretic peptide. J Clin Invest 86: 52-59, 1990
14. Gibb BJ, Wykes V, Garthwaite J. Properties of NO-activated guanylyl cyclases expressed in cells. Br J Pharmacol 139: 1032-1040, 2003
15. Gobeil F Jr, Dumont I, Marrache AM, Vazquez-Tello A, Bernier SG, Abran D, Hou X, Beauchamp MH, Quiniou C, Bouayad A, Choufani S, Bhattacharya M, Melotchnikoff S, Ribeiro-da-Silva A, Varma DR, Bkaily G, Chemtob S. Regulation of eNOS expression in brain endothelial cells by perinuclear EP3 receptors. Circ Res 90: 682-689, 2002
16. Guan Y, Stillman BA, Zhang Y, Schneider A, Saito O, Davis LS, Redha R, Breyer RM, Breyer MD. Cloning and expression of the rabbit prostaglandin EP2 receptor. BMC Pharmacology 2: 14-24, 2002
17. 1 analog alprostadil induces VEGF and eNOS expression in endothelial cells. Am J Physiol 289: H2066-H2072, 2005
18. Hayes JS, Brunton LL, Brown JH, Reese JB, Mayer SE. Hormonally specific expression of cardiac protein kinase activity. Proc Natl Acad Sci USA 76: 1570-1574, 1979
19. 0 of myocardial infarct size in the rabbit by activation of ATP-sensitive potassium channels. Br J Pharmacol 116: 2435-2440, 1995
20. 2 subtype. J Biol Chem 268: 7759-7762, 1993
21. 2 on myocardial infarct size after coronary occlusion in conscious dogs. Circ Res 49: 685-700, 1981
22. Kraemer RJ, Phernetton TM, Folts JD. Prostaglandin-like substances in coronary venous blood following myocardial ischemia. J Pharmacol Exp Ther 199: 611-619, 1976
23. Lee SJ, Kim SZ, Cui X, Kim SH, Lee KS, Chung YJ, Cho KW. C-type natriuretic peptide inhibits ANP secretion and atrial dynamics in perfused atria: NPR-B-cGMP signaling. Am J Physiol 278: H208-H221, 2000
24. 2 receptor-cAMP-protein kinase signaling. Am J Physiol 285: R380-R393, 2003
25. Matsuzawa H, Nirenberg M. Receptor-mediated shifts in cGMP and cAMP levels in neuroblastoma cells. Proc Natl Acad Sci USA 72: 3472-3476, 1975
26. Namkoong S, Lee SJ, Kim CK, Kim YM, Chung HT, Lee H, Han JA, Ha KS, Kwon YG, Kim YM. Prostaglandin E2 stimulates angiogenesis by activating the nitric oxide/cGMP pathway in human umbilical vein endothelial cells. Exp Mol Med 37: 588-600, 2005
27. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: Structures, Properties, and Functions. Physiol Rev 79: 1193-1226, 1999
28. Sakai M, Minami T, Hara N, Nishihara I, Kitade H, Kamiyama Y, Okuda K, Takahashi H, Mori H, Ito S. Stimulation of nitric oxide release from rat spinal cord by prostaglandin E2. Brit J Pharmacol 123: 890-894, 1998
29. Thiemermann C, Zacharowski K. Selective activation of E-type prostanoid3-receptors reduces myocardial infarct size. A novel insight into the cardioprotective effects of prostaglandins. Pharmacol Ther 87: 61-67, 2000
30. Wen JF, Cui X, Jin JY, Kim SM, Kim SZ, Kim SH, Lee HS, Cho KW. High and low gain switches for regulation of camp efflux concentration. Distinct roles for particulate GC- and soluble GC-cGMP-PDE3 signaling in rabbit atria. Circ Res 94: 936-943, 2004
31. Wilson RJ, Rhodes SA, Wood RL, Shield VJ, Noel LS, Gray DW, Giles H. Functional Pharmacology of human prostanoid EP2 and EP4 receptors. Eur J Pharmacol 501: 49-58, 2004
32. 2-type 1 receptor increases rat atrial contractility via a Y-27632-sensitive pathway. Prostaglandins Other Lipid Mediat 70: 91-105, 2002
33. 2 protects the heart from ischemia-reperfusion injury via its receptor subtype EP4. Circulation 109: 2462-2468, 2004